The Asia Pacific antibody discovery market is observing robust expansion, fueled by a rising prevalence of chronic illnesses and a greater focus on personalized healthcare. Significant investment in research and progression, particularly within nations like China, Japan, and East Korea, is stimulating the adoption of advanced antibody discovery tec